How does cost affect access to healthcare?

‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

Charitable Pharmacies of America organization member receives Health Equity grant

St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.

One in four Americans say they struggle to afford their prescription medications. The establishment of this Charitable Pharmacy in Milford will allow patients who live east of Cincinnati better access to care.

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

Charitable Pharmacies of America organization member receives Health Equity grant

The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming

Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.